| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Copper | 14 | 2019 | 149 | 4.970 |
Why?
|
| Disinfection | 11 | 2019 | 112 | 4.130 |
Why?
|
| Cross Infection | 11 | 2019 | 195 | 3.940 |
Why?
|
| Disinfectants | 7 | 2019 | 61 | 2.790 |
Why?
|
| Anti-Infective Agents | 7 | 2018 | 166 | 2.780 |
Why?
|
| Environmental Microbiology | 7 | 2019 | 25 | 2.640 |
Why?
|
| Bacteria | 10 | 2019 | 193 | 2.260 |
Why?
|
| Fomites | 4 | 2019 | 12 | 1.610 |
Why?
|
| Intensive Care Units | 4 | 2013 | 344 | 1.210 |
Why?
|
| Alloys | 3 | 2017 | 66 | 1.200 |
Why?
|
| Infection Control | 3 | 2016 | 101 | 1.120 |
Why?
|
| Fatty Liver | 14 | 2014 | 97 | 1.090 |
Why?
|
| Beds | 3 | 2019 | 13 | 1.030 |
Why?
|
| Bacterial Load | 3 | 2016 | 24 | 0.990 |
Why?
|
| Reperfusion Injury | 12 | 2014 | 320 | 0.930 |
Why?
|
| Bacterial Infections | 3 | 2015 | 163 | 0.870 |
Why?
|
| Colony Count, Microbial | 7 | 2019 | 77 | 0.810 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 156 | 0.800 |
Why?
|
| Patients' Rooms | 3 | 2016 | 15 | 0.760 |
Why?
|
| HIV-1 | 6 | 1999 | 177 | 0.720 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2003 | 50 | 0.680 |
Why?
|
| Escherichia coli Proteins | 7 | 2003 | 65 | 0.680 |
Why?
|
| Membrane Transport Proteins | 7 | 2003 | 81 | 0.670 |
Why?
|
| Decontamination | 1 | 2019 | 11 | 0.660 |
Why?
|
| Microbial Viability | 1 | 2019 | 27 | 0.660 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2016 | 101 | 0.650 |
Why?
|
| Escherichia coli | 9 | 2016 | 368 | 0.650 |
Why?
|
| Anti-Bacterial Agents | 5 | 2019 | 1026 | 0.640 |
Why?
|
| Adenosine Triphosphatases | 6 | 2002 | 83 | 0.610 |
Why?
|
| Students, Dental | 1 | 2018 | 49 | 0.600 |
Why?
|
| Stethoscopes | 1 | 2017 | 4 | 0.580 |
Why?
|
| Environmental Exposure | 1 | 2019 | 269 | 0.560 |
Why?
|
| Intermediate Care Facilities | 1 | 2016 | 2 | 0.550 |
Why?
|
| Hospitals, Rural | 1 | 2016 | 43 | 0.540 |
Why?
|
| Equipment Contamination | 2 | 2017 | 38 | 0.530 |
Why?
|
| Bacterial Proteins | 6 | 2002 | 245 | 0.530 |
Why?
|
| Environment Design | 1 | 2015 | 40 | 0.500 |
Why?
|
| Gene Products, rev | 3 | 1999 | 8 | 0.500 |
Why?
|
| RNA, Viral | 3 | 1999 | 93 | 0.480 |
Why?
|
| Liver | 11 | 2014 | 1118 | 0.470 |
Why?
|
| Liver Transplantation | 7 | 2010 | 400 | 0.450 |
Why?
|
| Biota | 1 | 2012 | 3 | 0.420 |
Why?
|
| Air Conditioning | 1 | 2012 | 3 | 0.420 |
Why?
|
| Fungi | 1 | 2012 | 27 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 3 | 2003 | 615 | 0.410 |
Why?
|
| Durable Medical Equipment | 1 | 2011 | 1 | 0.410 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 91 | 0.380 |
Why?
|
| Health Facility Environment | 1 | 2011 | 11 | 0.380 |
Why?
|
| Facility Design and Construction | 1 | 2011 | 16 | 0.370 |
Why?
|
| Mitochondrial Proteins | 6 | 2013 | 113 | 0.370 |
Why?
|
| Humans | 30 | 2023 | 68618 | 0.350 |
Why?
|
| Ion Channels | 6 | 2013 | 72 | 0.340 |
Why?
|
| Protein Precursors | 2 | 1999 | 105 | 0.320 |
Why?
|
| HIV Protease | 2 | 1998 | 7 | 0.320 |
Why?
|
| Kupffer Cells | 3 | 2014 | 75 | 0.310 |
Why?
|
| Hospitals | 4 | 2019 | 265 | 0.290 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 848 | 0.280 |
Why?
|
| Research Design | 1 | 2011 | 729 | 0.270 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2017 | 92 | 0.270 |
Why?
|
| Ceruletide | 1 | 2004 | 8 | 0.240 |
Why?
|
| Fatty Acid Synthases | 1 | 2004 | 6 | 0.240 |
Why?
|
| Intention to Treat Analysis | 2 | 2015 | 38 | 0.240 |
Why?
|
| Viral Proteins | 3 | 2003 | 150 | 0.240 |
Why?
|
| Molecular Sequence Data | 9 | 2003 | 1447 | 0.230 |
Why?
|
| Gram-Positive Cocci | 1 | 2003 | 5 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2016 | 133 | 0.220 |
Why?
|
| Interleukin-10 | 3 | 2014 | 144 | 0.220 |
Why?
|
| Base Sequence | 8 | 2003 | 1015 | 0.220 |
Why?
|
| Hot Temperature | 1 | 2003 | 152 | 0.210 |
Why?
|
| Pseudomonas putida | 1 | 2002 | 4 | 0.210 |
Why?
|
| Benzene | 1 | 2002 | 9 | 0.210 |
Why?
|
| Micropore Filters | 1 | 2002 | 5 | 0.210 |
Why?
|
| Benzene Derivatives | 1 | 2002 | 12 | 0.210 |
Why?
|
| Gases | 1 | 2002 | 17 | 0.210 |
Why?
|
| Waste Management | 1 | 2002 | 11 | 0.210 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2002 | 13 | 0.210 |
Why?
|
| RNA, Messenger | 6 | 2014 | 1664 | 0.200 |
Why?
|
| Bioreactors | 1 | 2002 | 65 | 0.200 |
Why?
|
| Gene Products, gag | 2 | 1998 | 11 | 0.200 |
Why?
|
| Air Pollutants | 1 | 2002 | 75 | 0.190 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2023 | 148 | 0.190 |
Why?
|
| Gram-Negative Bacteria | 2 | 2017 | 55 | 0.190 |
Why?
|
| Microcephaly | 1 | 2021 | 6 | 0.190 |
Why?
|
| Mice, Obese | 7 | 2013 | 33 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2003 | 447 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2011 | 114 | 0.170 |
Why?
|
| Prospective Studies | 3 | 2017 | 3705 | 0.170 |
Why?
|
| Mice | 17 | 2014 | 8474 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 86 | 0.170 |
Why?
|
| Introns | 1 | 1999 | 68 | 0.170 |
Why?
|
| SEC Translocation Channels | 6 | 2002 | 9 | 0.160 |
Why?
|
| Adenosine Triphosphate | 5 | 2011 | 314 | 0.160 |
Why?
|
| Ribonucleoproteins | 1 | 1998 | 19 | 0.160 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 92 | 0.160 |
Why?
|
| Bacteriophage P1 | 3 | 2003 | 11 | 0.160 |
Why?
|
| Capsid | 1 | 1998 | 8 | 0.160 |
Why?
|
| Alanine Transaminase | 5 | 2014 | 137 | 0.160 |
Why?
|
| RNA | 1 | 1999 | 171 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 226 | 0.150 |
Why?
|
| Water Pollutants, Chemical | 1 | 2002 | 328 | 0.150 |
Why?
|
| Dental Care | 1 | 2018 | 34 | 0.150 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 439 | 0.150 |
Why?
|
| Mice, Knockout | 6 | 2011 | 1692 | 0.150 |
Why?
|
| Hepatocytes | 3 | 2011 | 205 | 0.150 |
Why?
|
| Male | 15 | 2022 | 37321 | 0.150 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2017 | 6 | 0.150 |
Why?
|
| Animals | 19 | 2016 | 20881 | 0.140 |
Why?
|
| Diamines | 1 | 2016 | 9 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 1999 | 597 | 0.140 |
Why?
|
| Glass Ionomer Cements | 1 | 2016 | 8 | 0.140 |
Why?
|
| Streptococcus mutans | 1 | 2016 | 11 | 0.140 |
Why?
|
| Iodides | 1 | 2016 | 15 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2018 | 254 | 0.130 |
Why?
|
| Acrylic Resins | 1 | 2016 | 48 | 0.130 |
Why?
|
| Chile | 1 | 2015 | 17 | 0.130 |
Why?
|
| Protein Biosynthesis | 2 | 1999 | 181 | 0.130 |
Why?
|
| Oxygen | 2 | 2011 | 386 | 0.130 |
Why?
|
| Uncoupling Protein 2 | 6 | 2013 | 18 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2015 | 67 | 0.130 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 3 | 1999 | 8 | 0.120 |
Why?
|
| Child | 2 | 2016 | 6405 | 0.120 |
Why?
|
| Chromatography, Affinity | 1 | 1994 | 73 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 2791 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2016 | 525 | 0.120 |
Why?
|
| Plasmids | 4 | 2003 | 258 | 0.120 |
Why?
|
| Necrosis | 6 | 2013 | 239 | 0.120 |
Why?
|
| Cerulenin | 1 | 2013 | 4 | 0.110 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2013 | 5 | 0.110 |
Why?
|
| Curriculum | 1 | 2018 | 575 | 0.110 |
Why?
|
| Vancomycin Resistance | 1 | 2013 | 18 | 0.110 |
Why?
|
| Enterococcus | 1 | 2013 | 29 | 0.110 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2013 | 35 | 0.110 |
Why?
|
| Time Factors | 3 | 2018 | 4655 | 0.110 |
Why?
|
| Lac Operon | 2 | 2003 | 54 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2018 | 657 | 0.110 |
Why?
|
| Collagen | 1 | 2016 | 636 | 0.110 |
Why?
|
| Bacteriophages | 2 | 2003 | 24 | 0.110 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 1083 | 0.100 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 11 | 0.100 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 23 | 0.100 |
Why?
|
| Aluminum | 1 | 2012 | 21 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.100 |
Why?
|
| Transfection | 4 | 2013 | 782 | 0.100 |
Why?
|
| Biodegradation, Environmental | 2 | 2002 | 92 | 0.100 |
Why?
|
| Phlebotomy | 1 | 2011 | 17 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2018 | 2358 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 1506 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 43 | 0.100 |
Why?
|
| Graft Survival | 2 | 2004 | 465 | 0.100 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 92 | 0.100 |
Why?
|
| DNA, Bacterial | 2 | 2002 | 150 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2003 | 183 | 0.100 |
Why?
|
| Ischemia | 3 | 2011 | 229 | 0.100 |
Why?
|
| Housekeeping, Hospital | 1 | 2011 | 1 | 0.100 |
Why?
|
| Female | 6 | 2022 | 38074 | 0.090 |
Why?
|
| Hygiene | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cell Death | 4 | 2013 | 329 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2016 | 2455 | 0.090 |
Why?
|
| Vitamin E | 1 | 2009 | 55 | 0.090 |
Why?
|
| Warm Ischemia | 1 | 2009 | 8 | 0.090 |
Why?
|
| Primary Graft Dysfunction | 1 | 2009 | 12 | 0.090 |
Why?
|
| Infant | 1 | 2016 | 2891 | 0.090 |
Why?
|
| Child, Preschool | 1 | 2016 | 3187 | 0.080 |
Why?
|
| RNA Splicing | 2 | 1999 | 32 | 0.080 |
Why?
|
| Tocopherols | 1 | 2008 | 7 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 219 | 0.080 |
Why?
|
| Endotoxins | 2 | 2009 | 76 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1603 | 0.080 |
Why?
|
| Fatty Acids | 2 | 2011 | 222 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2011 | 384 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 1999 | 305 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2011 | 1342 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1076 | 0.070 |
Why?
|
| Cell Line | 3 | 2003 | 1752 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2279 | 0.070 |
Why?
|
| Biological Transport | 2 | 2010 | 210 | 0.060 |
Why?
|
| Liver Circulation | 1 | 2005 | 40 | 0.060 |
Why?
|
| Catechin | 1 | 2005 | 26 | 0.060 |
Why?
|
| Adult | 3 | 2023 | 21403 | 0.060 |
Why?
|
| DNA Primers | 3 | 2002 | 302 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 337 | 0.060 |
Why?
|
| Liver Failure | 1 | 2004 | 27 | 0.060 |
Why?
|
| Mutation | 2 | 2021 | 1213 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 562 | 0.060 |
Why?
|
| DNA, Viral | 2 | 2002 | 114 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2016 | 326 | 0.060 |
Why?
|
| Operator Regions, Genetic | 1 | 2003 | 5 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1995 | 204 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 50 | 0.050 |
Why?
|
| Clodronic Acid | 2 | 2014 | 9 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 304 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 2550 | 0.050 |
Why?
|
| Xylenes | 1 | 2002 | 3 | 0.050 |
Why?
|
| Michigan | 1 | 2022 | 68 | 0.050 |
Why?
|
| Bacteriophage M13 | 1 | 2002 | 12 | 0.050 |
Why?
|
| Volatilization | 1 | 2002 | 13 | 0.050 |
Why?
|
| Soil Microbiology | 1 | 2002 | 21 | 0.050 |
Why?
|
| Biotransformation | 1 | 2002 | 69 | 0.050 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 14 | 0.050 |
Why?
|
| Biomass | 1 | 2002 | 26 | 0.050 |
Why?
|
| Porosity | 1 | 2002 | 63 | 0.050 |
Why?
|
| Soil Pollutants | 1 | 2002 | 42 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 155 | 0.050 |
Why?
|
| Diffusion | 1 | 2002 | 90 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2001 | 9 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 191 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2001 | 18 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2005 | 222 | 0.050 |
Why?
|
| Toluene | 1 | 2002 | 37 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2013 | 189 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 511 | 0.050 |
Why?
|
| Virus Replication | 1 | 2002 | 104 | 0.050 |
Why?
|
| Temperature | 2 | 2001 | 341 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 498 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 103 | 0.050 |
Why?
|
| Ataxia | 1 | 2021 | 11 | 0.050 |
Why?
|
| Microscopy, Electron | 2 | 2016 | 351 | 0.050 |
Why?
|
| Water | 1 | 2022 | 230 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2003 | 291 | 0.050 |
Why?
|
| Ocular Motility Disorders | 1 | 2021 | 15 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 24 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2014 | 714 | 0.050 |
Why?
|
| Lipid Peroxidation | 2 | 2011 | 94 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 2021 | 114 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 474 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 49 | 0.040 |
Why?
|
| Cell-Free System | 1 | 1999 | 43 | 0.040 |
Why?
|
| Patient Care | 1 | 2019 | 61 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1999 | 25 | 0.040 |
Why?
|
| Models, Biological | 2 | 2002 | 981 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 92 | 0.040 |
Why?
|
| COS Cells | 1 | 1999 | 155 | 0.040 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 1998 | 7 | 0.040 |
Why?
|
| Genes, rev | 1 | 1998 | 4 | 0.040 |
Why?
|
| Algorithms | 1 | 2004 | 1196 | 0.040 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 1998 | 2 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1999 | 155 | 0.040 |
Why?
|
| Nucleocapsid | 1 | 1998 | 1 | 0.040 |
Why?
|
| pol Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 1 | 0.040 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 5 | 0.040 |
Why?
|
| Magnesium | 1 | 1999 | 110 | 0.040 |
Why?
|
| HIV Antigens | 1 | 1998 | 9 | 0.040 |
Why?
|
| Cell Extracts | 1 | 1998 | 21 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 144 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1998 | 89 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 1619 | 0.040 |
Why?
|
| Body Weight | 2 | 2013 | 554 | 0.040 |
Why?
|
| beta-Galactosidase | 2 | 2001 | 88 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2673 | 0.040 |
Why?
|
| Aged | 1 | 2013 | 14862 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 271 | 0.040 |
Why?
|
| Epilepsy | 1 | 2021 | 336 | 0.040 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2016 | 7 | 0.030 |
Why?
|
| Dentin | 1 | 2016 | 14 | 0.030 |
Why?
|
| Hardness | 1 | 2016 | 20 | 0.030 |
Why?
|
| Molar | 1 | 2016 | 27 | 0.030 |
Why?
|
| South Carolina | 1 | 2023 | 2752 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2016 | 38 | 0.030 |
Why?
|
| Beryllium | 1 | 1996 | 5 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 59 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 137 | 0.030 |
Why?
|
| Biofilms | 1 | 2016 | 72 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 201 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1745 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2016 | 289 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 943 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 881 | 0.030 |
Why?
|
| Middle Aged | 1 | 2013 | 21147 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 1293 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 363 | 0.030 |
Why?
|
| Sepharose | 1 | 1994 | 18 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 175 | 0.030 |
Why?
|
| Materials Testing | 1 | 2016 | 263 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 765 | 0.030 |
Why?
|
| Monocytes | 1 | 1996 | 210 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 492 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 43 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 88 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 31 | 0.030 |
Why?
|
| Liver Regeneration | 1 | 2013 | 38 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2013 | 89 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2013 | 31 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 87 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2013 | 237 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 626 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2013 | 95 | 0.030 |
Why?
|
| Nanoparticles | 1 | 2016 | 254 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2011 | 10 | 0.030 |
Why?
|
| Emulsions | 1 | 2011 | 10 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 770 | 0.030 |
Why?
|
| Operon | 1 | 1991 | 7 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 34 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 181 | 0.020 |
Why?
|
| Phospholipids | 1 | 2011 | 108 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 93 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 324 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2010 | 31 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1991 | 376 | 0.020 |
Why?
|
| Succinates | 1 | 2009 | 9 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 35 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 201 | 0.020 |
Why?
|
| Liposomes | 1 | 2010 | 107 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 84 | 0.020 |
Why?
|
| Leptin | 1 | 2009 | 80 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2009 | 75 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 901 | 0.020 |
Why?
|
| DNA Damage | 1 | 2009 | 190 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 241 | 0.020 |
Why?
|
| Reperfusion | 1 | 2008 | 78 | 0.020 |
Why?
|
| Thyroxine | 1 | 2008 | 62 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 371 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 455 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2008 | 99 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 244 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 330 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 226 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 343 | 0.020 |
Why?
|
| Cytokines | 1 | 2011 | 866 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 2689 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 1056 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 5717 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2004 | 14 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 947 | 0.020 |
Why?
|
| Energy Intake | 1 | 2005 | 123 | 0.010 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2003 | 14 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2003 | 32 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2003 | 44 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 8912 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 252 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 200 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 546 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2003 | 41 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 195 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2002 | 12 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2002 | 85 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 81 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 231 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 1040 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 248 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 1047 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 357 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 208 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 173 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 710 | 0.010 |
Why?
|
| Mitochondria | 1 | 2003 | 643 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1641 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1996 | 50 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1996 | 39 | 0.010 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 1995 | 4 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1995 | 11 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1996 | 86 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 251 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 852 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 1995 | 215 | 0.010 |
Why?
|